TuHURA Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | ||
EBITDA | -2,192 | -4,552 |
EBIT | -2,209 | -4,587 |
Net Income | -2,161 | -4,842 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -1,889 | -3,834 |
Cash | 3,020 | 4,461 |
Basic Shares | 42,030 | 42,030 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -29,120 | -9,560 | -6,006 |
EBIT | -29,298 | -9,933 | -6,387 |
Net Income | -29,316 | -9,367 | -7,016 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -12,030 | -7,544 | -6,566 |
Cash | 3,665 | 14,252 | 5,546 |
Basic Shares | 68,013 | 46 | 42,030 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.47 |
2024-03-31 | -$1.58 |
2023-12-31 | -$8.27 |
2023-09-30 | -$63.90 |
